Overview
Chongze Yuan practices practicing medicine in Shanghai, China.
Yuan is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Lung Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma.
They are actively involved in clinical research, co-authoring 21 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chongze Yuan
Is Chongze Yuan a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Chongze Yuan is classified as an Advanced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chongze Yuan participate in research or clinical trials?
Yes. Chongze Yuan has published 21 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Chongze Yuan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung AdenocarcinomaYuan isAdvanced. Learn about Lung Adenocarcinoma.
- Experienced
- Lung CancerYuan isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Squamous Cell Lung Carcinoma